Timeline

Vincent Enouf

Deputy Director of National Reference Center

30 Sep 2024

publication

Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies

26 Sep 2024

publication

Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.

01 Sep 2024

publication

Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine

26 Aug 2024

publication

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

01 Jul 2024

publication

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans

01 Jul 2024

publication

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

23 May 2024

publication

Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine.

28 Mar 2024

publication

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

01 Mar 2024

publication

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.

22 Feb 2024

publication

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

01 Feb 2024

publication

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.

01 Jan 2024

publication

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

01 Jan 2024

publication

Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

01 Nov 2023

publication

Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022

01 Nov 2023

publication

Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.

25 Aug 2023

publication

Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic

01 Jun 2023

publication

Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique.

01 Jun 2023

publication

Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique

02 Feb 2023

publication

Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic

02 Feb 2023

publication

Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic.

01 Jan 2023

publication

Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic.

11 Nov 2022

publication

Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis

01 Sep 2021

publication

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.

20 Jan 2021

publication

Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification

02 Sep 2020

publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

04 Aug 2020

publication

Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.

01 Jul 2020

publication

Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.

31 Jan 2020

news

Coronavirus : Mobilisation Equipes de l’Institut Pasteur

28 Jan 2020

news

Coronavirus de Wuhan

18 Jun 2019

project

Welcome to the Nanopore User Group at Institut Pasteur webpage

04 Jul 2017

news

Real-Time Whole-Genome Sequencing for Surveillance of Listeria monocytogenes

24 May 2017

news

Emerging diseases: a highly mutant strain of the Elizabethkingia bacterium caused an outbreak in Wisconsin

10 Oct 2016

news

A population biology study of Listeria ushers in a new era in listeriosis surveillance

06 Jun 2016

team

Mutualized Platform for Microbiology

27 Jul 2015

nrc

Viruses of Respiratory Infections (including Influenza and SARS-CoV-2)

01 Jul 2015

publication

Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France

12 May 2015

publication

Erratum to: Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review

29 Jan 2015

publication

Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype

29 Jan 2015

publication

Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review

08 May 2014

publication

Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1)

13 Nov 2013

publication

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

03 Jul 2013

publication

Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections–the Fluco French cohort

13 Jun 2013

publication

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013

30 May 2013

publication

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

31 Jan 2013

publication

Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe

24 Aug 2012

publication

I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y

14 Aug 2012

publication

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections

09 Jun 2012

publication

HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains

22 Mar 2012

publication

Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France

20 Jan 2012

publication

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter

15 Dec 2011

publication

S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses

27 Oct 2011

publication

Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France

30 Jun 2011

publication

Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe

29 Jun 2011

publication

Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes

01 Apr 2011

publication

Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus.

09 Dec 2010

publication

Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009

02 Nov 2010

publication

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial

01 Oct 2009

publication

Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007

22 Jul 2009

publication

Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.

11 Jun 2009

publication

Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries

27 May 2009

publication

[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?]

01 Apr 2009

publication

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

01 Jan 2009

publication

Guillain-Barré syndrome and influenza virus infection

25 Jul 2008

publication

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

14 Feb 2007

publication

Acute bilateral uveitis associated with an active human herpesvirus-6 infection

01 Sep 2006

publication

Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia

01 Aug 2006

publication

Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens

01 Dec 2005

publication

Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad

01 Nov 2004

publication

Evidence for hepatitis E virus quasispecies

01 Jun 2003

publication

Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1

01 May 2002

publication

Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells

01 Apr 2001

publication

A little guide for advanced search:

Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies

Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.

Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine.

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022

Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.

Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic

Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique.

Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique

Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic

Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic.

Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic.

Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.

Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.

Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.

Coronavirus : Mobilisation Equipes de l’Institut Pasteur

Coronavirus de Wuhan

Welcome to the Nanopore User Group at Institut Pasteur webpage

Real-Time Whole-Genome Sequencing for Surveillance of Listeria monocytogenes

Emerging diseases: a highly mutant strain of the Elizabethkingia bacterium caused an outbreak in Wisconsin

A population biology study of Listeria ushers in a new era in listeriosis surveillance

Mutualized Platform for Microbiology

Viruses of Respiratory Infections (including Influenza and SARS-CoV-2)

Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France

Erratum to: Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review

Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype

Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review

Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1)

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections–the Fluco French cohort

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe

I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections

HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains

Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter

S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses

Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France

Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe

Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes

Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus.

Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial

Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007

Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.

Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries

[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?]

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

Guillain-Barré syndrome and influenza virus infection

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

Acute bilateral uveitis associated with an active human herpesvirus-6 infection

Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia

Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens

Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad

Evidence for hepatitis E virus quasispecies

Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1

Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells

Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic